Literature DB >> 31960389

Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth.

Mitsunobu Saito1, Noriyuki Akutsu2, Yasunao Numata1, Keisuke Ishigami1, Shigeru Sasaki1, Hiroshi Nakase1.   

Abstract

This is the first case involving the development of anti-centromere antibody (ACA)-positive autoimmune hepatitis (AIH) after childbirth that triggered nailfold bleeding. A 32-year-old woman visited a dermatologist presenting with nailfold bleeding 6 months after the delivery of her second baby. Blood tests revealed liver dysfunction, and she was admitted to our hospital. Tests for hepatitis virus, antinuclear antibody, and anti-mitochondrial antibody were negative. She had no history of alcohol consumption or oral medication. Because of nailfold bleeding, we performed tests for ACA, anti-Scl-70 antibody, anti-RNA polymerase III antibody, and anti-U1 RNP antibodies; only ACA was positive. A liver biopsy was performed for the diagnosis of liver dysfunction. Histological examination of the liver biopsy specimen showed moderate infiltration of inflammatory cells, interface hepatitis, bridging fibrosis, and bile duct injury. The AIH international score was 17, and thus, we diagnosed AIH. Oral prednisolone (PSL) 0.6 mg/day/body weight was initiated. Two weeks post-treatment, the liver enzyme levels normalized and the nailfold bleeding disappeared. In case of nailfold bleeding complicated with liver dysfunction post-childbirth, ACA-positive AIH should be considered as a differential diagnosis.

Entities:  

Keywords:  Anti-centromere antibody; Autoimmune hepatitis; Nailfold bleeding

Mesh:

Substances:

Year:  2020        PMID: 31960389     DOI: 10.1007/s12328-020-01092-w

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  3 in total

1.  The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.

Authors:  Hyun Jin Cha; Jimin Hwang; Lucy Eunju Lee; Younhee Park; Jason Jungsik Song
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

2.  Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"

Authors:  Pier Leopoldo Capecchi; Pietro Enea Lazzerini; Stefano Brillanti
Journal:  J Hepatol       Date:  2021-05-05       Impact factor: 25.083

3.  Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments.

Authors:  Shuhui Wang; Zheng Huang; Yu Lei; Xu Han; Dean Tian; Jin Gong; Mei Liu
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.